As you will be reminded at the end of this article, penny stocks are incredibly dangerous. Of course, we are all naturally attracted to a low price tag. However, there’s a big difference between a discounted opportunity and a cheap one. The former may have some real potential, but the latter can leave you stranded.…

Investors today have their eyes on a newly popping biotech play Outlook Therapeutics (NASDAQ:OTLK). The company is reporting its newest clinical trial data today. With the positive results, it seems as though buyers are flocking to the play. So, what’s going on with OTLK stock today? Source: Shutterstock Outlook Therapeutics is a New Jersey-based, clinical stage…